Company / CapEx per Share
Bicara Therapeutics Inc. CapEx per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.00
FY2023-FY2024
Trend
-99.6%
vs FY2023
Sector context
#187 of 192
Health Care
What the data says
Among 192 Health Care companies, Bicara Therapeutics Inc. is in the bottom 3% for capex per share.
Based on SEC 10-K filings.
0.00 in FY2024.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 192This company $0.00 Sector average $2.46
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 99.6% year-over-year.
- Ranks #187 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -99.6% |
| FY2023 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026